Skip to content
healthcare.dev

Thyroid-Adrenal

NDC 55714-2564, Adrenalinum, Thyroidinum, Aloe, Calc. carb., Chelidonium majus, Conium, Graphites, Iodium, Lachesis, Lycopodium, Lycopus virginicus, Phytolacca, Rhus toxicodendron, Silicea, Spongia, Echinacea, liquid, from Newton Laboratories, Inc..

Product NDC
55714-2564
Status
Listed
Labeler
Newton Laboratories, Inc.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55714-2564 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EPINEPHRINE15 [hp_X]/mL
  • THYROID, UNSPECIFIED15 [hp_X]/mL
  • ALOE15 [hp_X]/mL
  • OYSTER SHELL CALCIUM CARBONATE, CRUDE15 [hp_X]/mL
  • CHELIDONIUM MAJUS15 [hp_X]/mL
  • CONIUM MACULATUM FLOWERING TOP15 [hp_X]/mL
  • GRAPHITE15 [hp_X]/mL
  • IODINE15 [hp_X]/mL
  • LACHESIS MUTA VENOM15 [hp_X]/mL
  • LYCOPODIUM CLAVATUM SPORE15 [hp_X]/mL
  • LYCOPUS VIRGINICUS15 [hp_X]/mL
  • PHYTOLACCA AMERICANA ROOT15 [hp_X]/mL
  • TOXICODENDRON PUBESCENS LEAF15 [hp_X]/mL
  • SILICON DIOXIDE15 [hp_X]/mL
  • SPONGIA OFFICINALIS SKELETON, ROASTED15 [hp_X]/mL
  • ECHINACEA, UNSPECIFIED6 [hp_X]/mL

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Catecholamine [EPC]; Catecholamines [CS]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
55714-2564-15571425640130 mL in 1 BOTTLE, GLASS (55714-2564-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55714-2564 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55714-2564 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55714-2564. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.